Abvc Biopharma earnings were -$3.1M for the trailing 12 months ending Jun 30, 2025, with N/A growth year over year. The latest ABVC earnings report on Jun 30, 2025 announced Q2 2025 earnings of -$2.3M, up 168% from last quarter. For the last reported fiscal year 2024 ending Dec 31, 2024, ABVC reported annual earnings of -$4.9M, with -37% growth.
Abvc Biopharma (NASDAQ: ABVC) reported Q2 2025 earnings per share (EPS) of -$0.13, up 62.5% year over year. Total ABVC earnings for the quarter were -$2.26 million. In the same quarter last year, Abvc Biopharma's earnings per share (EPS) was -$0.08.
As of the last Abvc Biopharma earnings report, Abvc Biopharma is currently losing money. Abvc Biopharma's net profit (also called net income) for the twelve months ending Jun 30, 2025 was -$3.06 million, a 59.13% decrease year over year.
What was ABVC's earnings growth in the past year?
As of Abvc Biopharma's earnings date in Q3 2025, Abvc Biopharma's earnings has grown year over year. ABVC earnings in the past year totalled -$3.06 million.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.